IRIS
Paoletti, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.238
AS - Asia 2.769
EU - Europa 979
SA - Sud America 508
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 110
OC - Oceania 22
Totale 7.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.133
SG - Singapore 1.644
CN - Cina 486
BR - Brasile 421
IT - Italia 387
VN - Vietnam 248
FI - Finlandia 96
IE - Irlanda 88
HK - Hong Kong 82
DE - Germania 74
IN - India 64
GB - Regno Unito 59
FR - Francia 56
NG - Nigeria 55
CA - Canada 49
NL - Olanda 42
AR - Argentina 38
BD - Bangladesh 37
RU - Federazione Russa 29
MX - Messico 26
ID - Indonesia 22
SE - Svezia 22
ES - Italia 21
TR - Turchia 21
IQ - Iraq 20
PK - Pakistan 20
ZA - Sudafrica 20
AU - Australia 19
JP - Giappone 18
CZ - Repubblica Ceca 16
AT - Austria 13
EC - Ecuador 13
PL - Polonia 13
UA - Ucraina 13
EG - Egitto 12
MY - Malesia 12
SA - Arabia Saudita 12
BE - Belgio 11
CL - Cile 11
CO - Colombia 8
IL - Israele 8
LT - Lituania 7
NP - Nepal 7
PH - Filippine 7
KE - Kenya 6
TW - Taiwan 6
VE - Venezuela 6
AL - Albania 5
KR - Corea 5
SN - Senegal 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
DZ - Algeria 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
MA - Marocco 4
NI - Nicaragua 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
TH - Thailandia 4
BG - Bulgaria 3
CH - Svizzera 3
SV - El Salvador 3
TN - Tunisia 3
AZ - Azerbaigian 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IM - Isola di Man 1
Totale 7.618
Salva come PNG Salva come JPEG
Città #
Singapore 685
Ashburn 355
San Jose 335
The Dalles 242
Chandler 220
Shanghai 188
Dallas 147
New York 147
Wilmington 139
Beijing 104
Los Angeles 99
Helsinki 95
Boardman 94
Santa Clara 90
Dublin 87
Milan 85
Ho Chi Minh City 81
Hong Kong 75
San Mateo 63
Hanoi 59
Benin City 54
Buffalo 47
Rome 44
Princeton 38
Lawrence 33
Ann Arbor 29
Paris 29
São Paulo 29
Leawood 24
Naples 24
Seattle 23
Orem 21
Phoenix 21
Amsterdam 20
Council Bluffs 20
London 20
Charlotte 17
Belo Horizonte 14
Fairfield 14
Curitiba 12
Da Nang 12
Frankfurt am Main 12
Montreal 12
Toronto 12
Warsaw 12
Boston 11
Mumbai 11
Philadelphia 11
Pune 11
Tokyo 11
Assago 10
Brasília 10
Brooklyn 10
Genoa 10
Houston 10
San Francisco 10
Woodbridge 10
Atlanta 9
Brno 9
Cairo 9
Chennai 9
Chicago 9
Falkenstein 9
Figino 9
Haiphong 9
Munich 9
Newark 9
Parma 9
Rio de Janeiro 9
Stockholm 9
Bar Harbor 8
Corigliano Calabro 8
Hải Dương 8
Johannesburg 8
Mexico City 8
Porto Alegre 8
Campinas 7
Denver 7
Fayetteville 7
Guarulhos 7
Hyderabad 7
Kuala Lumpur 7
Ambivere 6
Guayaquil 6
Jumet 6
Miami 6
Nuremberg 6
Pasadena 6
Secaucus 6
Spring 6
Buenos Aires 5
Can Tho 5
Cape Town 5
Dakar 5
Florence 5
Jeddah 5
Joinville 5
Moscow 5
Olomouc 5
Rochester 5
Totale 4.413
Salva come PNG Salva come JPEG
Nome #
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 166
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 134
Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps 133
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 126
An academic allergy unit during COVID-19 pandemic in Italy. 118
Treatable traits in chronic rhinosinusitis with nasal polyps 106
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 103
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 101
New therapeutic approaches with biological drugs for eosinophilic granulomatosis with polyangiitis 100
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 100
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 98
Asthma from immune pathogenesis to precision medicine 94
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 94
Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists 90
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 89
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 89
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 89
Alpha1-antitrypsin deficiency and asthma 89
Biologic drugs and allergen immunotherapy: potential allies 88
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 88
New drugs in early-stage clinical trials for allergic rhinitis 85
One year of mepolizumab. Efficacy and safety in real-life in Italy 85
Interleukin-5 in the Pathophysiology of Severe Asthma 83
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 81
Impact of asthma on bronchiectasis severity and risk of exacerbations 81
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 81
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 80
Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes 79
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 78
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 75
Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests 75
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital 75
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 74
Immunostimulants in respiratory diseases: Focus on Pidotimod 74
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 74
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease? 73
Allergen immunotherapy in Italy: How, when, and why—A real-world study conducted through a patient association 73
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 73
Gastroesophageal reflux and asthma: when, how, and why 72
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 69
Critical evaluation of asthma biomarkers in clinical practice 69
Biologics and airway remodeling in severe asthma 65
Radiological Versus Clinical 1-Year Outcomes of Dupilumab in Refractory CRSwNP: A Real-Life Study 65
Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control 64
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 64
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 63
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 62
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 61
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines 60
COPD and biologic treatment: state of the art 60
SANI Clinical Remission definition: a useful tool in Severe Asthma management 59
Oral Immunotherapy with Standardized Peanut Extract: A Game-Changer for Peanut Allergy 59
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 59
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 58
Antibiotic use and associated factors in a large sample of hospitalised older people 58
Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity 57
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation 56
Care for Patients with Type-2 Chronic Rhinosinusitis 56
Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas 56
Biologics in severe asthma: the role of real-world evidence from registries 54
Comorbid allergic rhinitis and asthma: important clinical considerations 53
A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma 52
Vocal biomarkers correlate with FEV1 variations during methacholine challenge 51
Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist's Perceptions 50
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients 50
Clinical remission in severe asthma: lights and shadows on an ambitious goal 50
Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate 49
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by Dupilumab 48
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 47
Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era 47
Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions 47
Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis 46
Predictive value of tissue eosinophilia for dupilumab response in chronic rhinosinusitis with nasal polyps: A retrospective monocentric study 46
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 46
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 46
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital 46
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 46
Real-world data: A relevant component in the framework of scientific evidence 46
ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist 46
Asthma severity: the patient’s point of view 45
Comparability of Asthma Control Test (ACT) scores between self and physician administered test 45
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis 44
Vaping effects on asthma: results from a web survey and clinical investigation 44
Exhaled nitric oxide in asthma: from diagnosis to management 43
Assessing Nasal Obstruction Improvement in Dupilumab-Treated Patients With Active Anterior Rhinomanometry: A Preliminary Study 43
Current treatment strategies for seasonal allergic rhinitis: where are we heading? 43
Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line 43
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 43
Editorial comment on “Environmental influences on childhood asthma: Climate change” 41
Statistical advice provided by ChatGPT regarding an accepted article in Allergy 41
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 41
Prediction of Clinical Response to Dupilumab for CRSwNP Based on the Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS) Score 41
Questionnaire Validation: A User Guide for Allergy Research 41
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 40
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 40
Cross-Cultural Validation of the Short Version of the Questionnaire of Olfactory Disorders-Negative Statements into Italian: Towards Personalized Patient Care 40
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders 39
Editorial: pharmacotherapy and evidence-based medicine section 39
Allergen immunotherapy: effective on lung function? 39
The Present and Future of Allergen Immunotherapy in Personalized Medicine 39
Totale 6.626
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022187 0 1 11 41 0 0 4 29 8 22 59 12
2022/2023618 80 48 50 75 65 40 0 41 112 46 43 18
2023/2024868 76 68 164 37 34 85 72 44 21 36 72 159
2024/20251.434 69 25 28 30 38 137 77 108 254 302 161 205
2025/20264.054 484 231 229 398 209 177 1.015 226 220 281 224 360
2026/2027340 272 68 0 0 0 0 0 0 0 0 0 0
Totale 7.774